Your browser doesn't support javascript.
loading
A ten-gene DNA-damage response pathway gene expression signature predicts gemtuzumab ozogamicin response in pediatric AML patients treated on COGAAML0531 and AAML03P1 trials.
Gbadamosi, Mohammed O; Shastri, Vivek M; Elsayed, Abdelrahman H; Ries, Rhonda; Olabige, Oluwaseyi; Nguyen, Nam H K; De Jesus, Angelica; Wang, Yi-Cheng; Dang, Alice; Hirsch, Betsy A; Alonzo, Todd A; Gamis, Alan; Meshinchi, Soheil; Lamba, Jatinder K.
Afiliação
  • Gbadamosi MO; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, USA.
  • Shastri VM; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, USA.
  • Elsayed AH; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, USA.
  • Ries R; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Olabige O; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, USA.
  • Nguyen NHK; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, USA.
  • De Jesus A; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, USA.
  • Wang YC; COG Statistics and Data Center, Monrovia, CA, USA.
  • Dang A; COG Statistics and Data Center, Monrovia, CA, USA.
  • Hirsch BA; University of Minnesota, Minneapolis, MN, USA.
  • Alonzo TA; COG Statistics and Data Center, Monrovia, CA, USA.
  • Gamis A; Biostatistics Division, University of Southern California, Los Angeles, CA, USA.
  • Meshinchi S; Department of Hematology-Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
  • Lamba JK; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Leukemia ; 36(8): 2022-2031, 2022 08.
Article em En | MEDLINE | ID: mdl-35688939
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dano ao DNA / Leucemia Mieloide Aguda / Antineoplásicos Imunológicos / Gemtuzumab Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dano ao DNA / Leucemia Mieloide Aguda / Antineoplásicos Imunológicos / Gemtuzumab Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido